omniture
Yisheng Pharma

Latest News

Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment

GAITHERSBURG, Md. and AMBLER, Pa., Jan. 6, 2020 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yish...

2020-01-06 09:00 445

Yisheng Biopharma Receives GMP Certification from China NMPA for Production of Lyophilized Rabies Vaccine for Preventive Use

BEIJING, July 22, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2019-07-22 21:00 1588

Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors

BEIJING, June 27, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2019-06-27 09:00 1076

Yisheng Biopharma Announces Research Presentation of Immuno-Oncology Product at AACR Annual Meeting 2019

BEIJING, March 28, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopha...

2019-03-28 21:00 563

Yisheng Biopharma Announces Clearance from China FDA to Proceed with PIKA Rabies Vaccine Clinical Study

BEIJING, Oct. 8, 2018 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharm...

2018-10-08 21:00 540

Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia

BEIJING, July 19, 2018 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a bioph...

2018-07-19 21:00 509

The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Pancreatic Cancer Treatment

BEIJING, Feb. 26, 2018 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2018-02-26 22:00 423

Yisheng Biopharma Announces New Breakthrough Results on YS-ON-001 in Multiple Solid Tumor Experiments

BEIJING, Aug. 30, 2017 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2017-08-30 20:00 1512

Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patients with Advanced Solid Tumors

BEIJING, May 1, 2017 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharma...

2017-05-01 20:00 1627

Yisheng Biopharma to Present at BioPharma Asia Convention 2017 in Singapore

BEIJING, March 15, 2017 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2017-03-15 20:30 1435

US FDA Grants Orphan Drug Designation to Yisheng Biopharma's PIKA Rabies Vaccine

BEIJING, Jan. 4, 2017 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharma...

2017-01-04 21:30 1288

Yisheng Biopharma Announces Completion of Phase I Clinical Study of a Novel Hepatitis B Vaccine with PIKA Adjuvant

BEIJING, Nov. 21, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharm...

2016-11-21 22:00 1440

Yisheng Biopharma Announces Research Collaboration with The Scripps Research Institute in Developing New AIDS Vaccine

BEIJING and LA JOLLA, Calif., Nov. 7, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Bio...

2016-11-07 21:00 1421

The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Hepatocellular Carcinoma

BEIJING, Oct. 24, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharm...

2016-10-24 20:00 1017

The US FDA Granted Orphan Drug Designation to Yisheng Biopharma's Biological Product for Hepatocellular Carcinoma

BEIJING, Oct. 24, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biophar...

2016-10-24 08:00 2069

Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Positive Animal Results of Vaccine Against Ebola Virus

BEIJING and FORT DETRICK, Md., July 15, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd.  ("Yisheng...

2016-07-15 21:52 2080

Yisheng Biopharma Announces Positive Results of Phase I Clinical Trial of a Novel Rabies Vaccine with PIKA Adjuvant

BEIJING, Jan. 4, 2016 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharm...

2016-01-04 09:00 2975

Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Collaboration on New Vaccine Against Ebola Virus

BEIJING, Dec. 14, 2015 /PRNewswire/ -- Yisheng Biopharma Co., Ltd.  ("Yisheng Biopharma"), a biopha...

2015-12-14 09:30 3129